IGF2BP1 and hepatocellular carcinoma: This mechanism is analogous to other metabolic-immune interactions, such as those mediated by IGF2BP1 and PRMT3 (31), highlighting the essential role of metabolic reprogramming in immune escape during the progression of HCC.